Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
• Print ISBN: 9781719648035
eText ISBN:9781719651585
,Question 1
A newly certified Family Nurse Practitioner (FNP) begins
practicing in a primary care clinic. A 62-year-old patient
requests a refill of an opioid medication previously prescribed
by another clinician. The prescription drug monitoring program
(PDMP) reveals recent opioid prescriptions from multiple
prescribers over the past month. The patient reports that the
medications were obtained because "different clinics had
shorter wait times."
What is the best initial action by the APRN?
A. Refill the prescription because abrupt discontinuation may
cause withdrawal.
B. Decline to prescribe the medication, discuss the PDMP
findings with the patient, assess pain and substance use risk,
and develop an evidence-based treatment plan.
C. Report the patient immediately to law enforcement.
D. Prescribe a higher opioid dose to prevent uncontrolled pain.
Correct Answer: B
Rationale:
An APRN should integrate PDMP findings into a comprehensive
clinical assessment rather than making decisions based solely
,on database information. Discussing the findings openly,
reassessing pain, evaluating for opioid use disorder or misuse,
reviewing prior records when possible, and creating an
evidence-based treatment plan are appropriate first steps. If
opioid therapy continues, it should be supported by clear
clinical indications, informed consent, and ongoing monitoring.
• A: Inappropriate because prescribing should not continue
without reassessment.
• C: PDMP findings alone do not warrant law enforcement
involvement.
• D: Escalating the opioid dose without reassessment
increases patient risk and contradicts safe prescribing
principles.
Question 2
A Psychiatric-Mental Health Nurse Practitioner (PMHNP) is
evaluating a 28-year-old patient with newly diagnosed major
depressive disorder. Before prescribing medication, the APRN
conducts a medication reconciliation and discovers the patient
regularly takes an over-the-counter herbal supplement for
mood enhancement.
Which prescribing principle is most important before initiating
pharmacotherapy?
, A. Assume over-the-counter supplements are clinically
insignificant.
B. Discontinue all nonprescription products immediately.
C. Assess for potential drug-supplement interactions and
counsel the patient before prescribing.
D. Delay treatment until the patient permanently stops all
supplements.
Correct Answer: C
Rationale:
Medication reconciliation includes prescription drugs, OTC
medications, vitamins, and herbal products because many
supplements may alter drug metabolism or increase adverse
effects. Identifying potential interactions before prescribing
promotes medication safety and informed clinical decision-
making.
• A: Incorrect because herbal supplements may produce
significant pharmacologic interactions.
• B: Not all supplements require discontinuation.
• D: Delaying necessary treatment is not routinely indicated
when appropriate management strategies are available.
Question 3
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
• Print ISBN: 9781719648035
eText ISBN:9781719651585
,Question 1
A newly certified Family Nurse Practitioner (FNP) begins
practicing in a primary care clinic. A 62-year-old patient
requests a refill of an opioid medication previously prescribed
by another clinician. The prescription drug monitoring program
(PDMP) reveals recent opioid prescriptions from multiple
prescribers over the past month. The patient reports that the
medications were obtained because "different clinics had
shorter wait times."
What is the best initial action by the APRN?
A. Refill the prescription because abrupt discontinuation may
cause withdrawal.
B. Decline to prescribe the medication, discuss the PDMP
findings with the patient, assess pain and substance use risk,
and develop an evidence-based treatment plan.
C. Report the patient immediately to law enforcement.
D. Prescribe a higher opioid dose to prevent uncontrolled pain.
Correct Answer: B
Rationale:
An APRN should integrate PDMP findings into a comprehensive
clinical assessment rather than making decisions based solely
,on database information. Discussing the findings openly,
reassessing pain, evaluating for opioid use disorder or misuse,
reviewing prior records when possible, and creating an
evidence-based treatment plan are appropriate first steps. If
opioid therapy continues, it should be supported by clear
clinical indications, informed consent, and ongoing monitoring.
• A: Inappropriate because prescribing should not continue
without reassessment.
• C: PDMP findings alone do not warrant law enforcement
involvement.
• D: Escalating the opioid dose without reassessment
increases patient risk and contradicts safe prescribing
principles.
Question 2
A Psychiatric-Mental Health Nurse Practitioner (PMHNP) is
evaluating a 28-year-old patient with newly diagnosed major
depressive disorder. Before prescribing medication, the APRN
conducts a medication reconciliation and discovers the patient
regularly takes an over-the-counter herbal supplement for
mood enhancement.
Which prescribing principle is most important before initiating
pharmacotherapy?
, A. Assume over-the-counter supplements are clinically
insignificant.
B. Discontinue all nonprescription products immediately.
C. Assess for potential drug-supplement interactions and
counsel the patient before prescribing.
D. Delay treatment until the patient permanently stops all
supplements.
Correct Answer: C
Rationale:
Medication reconciliation includes prescription drugs, OTC
medications, vitamins, and herbal products because many
supplements may alter drug metabolism or increase adverse
effects. Identifying potential interactions before prescribing
promotes medication safety and informed clinical decision-
making.
• A: Incorrect because herbal supplements may produce
significant pharmacologic interactions.
• B: Not all supplements require discontinuation.
• D: Delaying necessary treatment is not routinely indicated
when appropriate management strategies are available.
Question 3
